Revelation Biosciences Inc. (NASDAQ: REVB) is -75.50% lower on its value in year-to-date trading and has touched a low of $1.55 and a high of $100.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The REVB stock was last observed hovering at around $1.91 in the last trading session, with the day’s loss setting it -0.28% off its average median price target of $15.00 for the next 12 months. It is also 89.13% off the consensus price target high of $15.00 offered by 1 analysts, but current levels are 89.13% higher than the price target low of $15.00 for the same period.
Currently trading at $1.63, the stock is -25.76% and -70.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.01 million and changing -14.66% at the moment leaves the stock -87.20% off its SMA200. REVB registered -95.43% loss for a year compared to 6-month loss of -88.30%.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
The stock witnessed a -43.01% gain in the last 1 month and extending the period to 3 months gives it a -80.83%, and is -24.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.81% over the week and 11.85% over the month.
Distance from 52-week low is 5.16% and -98.38% from its 52-week high.
Revelation Biosciences Inc. (REVB) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Revelation Biosciences Inc. (REVB) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Revelation Biosciences Inc. is expected to release its quarterly report on 05/16/2023.The EPS is expected to shrink by -373.70% this year
Revelation Biosciences Inc. (REVB) Top Institutional Holders
The shares outstanding are 21.05M, and float is at 0.54M with Short Float at 19.01%.
Revelation Biosciences Inc. (REVB) Insider Activity
A total of 0 insider transactions have happened at Revelation Biosciences Inc. (REVB) in the last six months, with sales accounting for 0 and purchases happening 0 times.